Michael Robert Martin, Chief Business Officer at Aurinia Pharmaceuticals Inc. (AUPH), sold 121,000 shares at $29.50 ($3.7M) on 2021-11-11, disclosed to the SEC on 2021-11-12.
Open-market sale of $3.7M AUPH by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.17 | 50,000 | $1.5M | 40.8% |
| 2 | $30.55 | 10,000 | $306K | 8.3% |
| 3 | $31.26 | 50,000 | $1.6M | 42.2% |
| 4 | $29.50 | 11,000 | $325K | 8.8% |
| Total | $30.59 avg | 121,000 | $3.7M | 100% |
| Filing → |
| AUPH | SELL | 2021-11-03 | $1.4M | — | Filing → |
| AUPH | SELL | 2021-09-22 | $2.7M | — | Filing → |
| AUPH | SELL | 2021-09-16 | $958K | — | Filing → |